Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats

Diabetic cardiomyopathy, especially myocardial ischemia reperfusion (I/R) injury, is a major cause of morbidity and mortality in type 2 diabetic patients. The increasing of basal p38 MAP Kinase (p38 MAPK) activation is a major factor that aggravates cardiac death on diabetic cardiomyopathy. In addit...

Full description

Saved in:
Bibliographic Details
Published in:Exp Ther Med
Main Authors: Sanit, Jantira, Prompunt, Eakkapote, Adulyaritthikul, Punyanuch, Nokkaew, Nuttikarn, Mongkolpathumrat, Podsawee, Kongpol, Kantapich, Kijtawornrat, Anusak, Petchdee, Soontaree, Barrère-Lemaire, Stephanie, Kumphune, Sarawut
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2019
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676201/
https://ncbi.nlm.nih.gov/pubmed/31410128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2019.7763
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items